Corrigendum to: Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease
- PMID: 33197243
- DOI: 10.1093/cvr/cvaa182
Corrigendum to: Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease
Erratum for
-
Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease.Cardiovasc Res. 2021 Feb 22;117(3):942-949. doi: 10.1093/cvr/cvaa100. Cardiovasc Res. 2021. PMID: 32289159 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
